Clinical trial
Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-GE) for COVID-19
NCT04701489 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasound Neural and Immunomodulation Treatment Evaluation Study (UMN-GE) for COVID-19
- Lead sponsor
- University of Minnesota
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 14, 2021
- Completion date
- April 7, 2021
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, cytokine storm, inflammation